Contact
searchSearch
HMP Global
Login

After Treatment

arrow
After Treatment
Focuses on comprehensive follow-up care, rehabilitation, and monitoring for cancer survivors. This stage, often referred to as Survivorship Care, is crucial to supporting long-term health and managing any lingering side effects.

ONLINE EXCLUSIVES
Building Better Oncology Pathways With Specialty Pharmacy Integration
06/26/2026
Kishen Patel, PharmD
Kishen Patel, PharmD, discusses how integrated specialty pharmacy services are improving adherence, patient engagement, and clinical outcomes in oral oncology care—and why this pharmacist-led model earned Innovation Award recognition at the...
Kishen Patel, PharmD, discusses how integrated specialty pharmacy services are improving adherence, patient engagement, and clinical outcomes in oral oncology care—and why this pharmacist-led model earned Innovation Award recognition at the...
Kishen Patel, PharmD, discusses...
06/26/2026
Journal of Clinical Pathways
Specialty Pharmacy, Clinical Pathways, Oncology
Videos
Building Better Oncology Pathways With Specialty Pharmacy Integration: Part 2
06/17/2026
Kishen Patel, PharmD
Kishen Patel, PharmD, explores how integrated specialty pharmacy services are helping health systems reduce acute care utilization, strengthen oncology pathways, and demonstrate the long-term value of pharmacist-led care.
Kishen Patel, PharmD, explores how integrated specialty pharmacy services are helping health systems reduce acute care utilization, strengthen oncology pathways, and demonstrate the long-term value of pharmacist-led care.
Kishen Patel, PharmD, explores...
06/17/2026
Journal of Clinical Pathways
Specialty Pharmacy, Clinical Pathways, Oncology
Videos
Building Better Oncology Pathways With Specialty Pharmacy Integration
06/17/2026
Kishen Patel, PharmD
In this interview, Kishen Patel, PharmD, discusses how pharmacist-led interventions and integrated specialty pharmacy services can improve adherence, address treatment barriers, and support better outcomes for patients receiving oral oncology...
In this interview, Kishen Patel, PharmD, discusses how pharmacist-led interventions and integrated specialty pharmacy services can improve adherence, address treatment barriers, and support better outcomes for patients receiving oral oncology...
In this interview, Kishen Patel,...
06/17/2026
Journal of Clinical Pathways
Trending From ACCC
Delivery of Psychosocial Care in Oncology Summit
08/08/2023
This column summarizes the sessions from the Association of Community Cancer Centers (ACCC) multistakeholder meeting, “A Call to Action: Delivery of Psychosocial Care in Oncology Summit,” which took place on March 8, 2023, in Washington, DC.
This column summarizes the sessions from the Association of Community Cancer Centers (ACCC) multistakeholder meeting, “A Call to Action: Delivery of Psychosocial Care in Oncology Summit,” which took place on March 8, 2023, in Washington, DC.
This column summarizes the...
08/08/2023
Journal of Clinical Pathways
Research Reports
Post–COVID-19 Syndrome Clinical Pathway for the US Veterans Health Administration
02/06/2023
Allison M. Gustavson, DPT, PhD; Johnson Vachachira, NP; Claudia L. Campos, MD; Jacob B. Lindheimer, PhD; Kristina Crothers, MD; Omar Awan, MD; Carrie B. May, PsyD; Cristina Nguyen, BS; Courtney Sedillo, MSN, FNP-C; Francis J. Miller, Jr., MD
Lindheimer et al summarize the stepwise diagnostic approach for patients presenting with PCS dyspnea and/or cough in primary care and highlight teleconsultation and telerehabilitation as opportunities to reach those in rural areas or with...
Lindheimer et al summarize the stepwise diagnostic approach for patients presenting with PCS dyspnea and/or cough in primary care and highlight teleconsultation and telerehabilitation as opportunities to reach those in rural areas or with...
Lindheimer et al summarize the...
02/06/2023
Journal of Clinical Pathways
Clinical Pathways GPS
Improving Diabetic Management in Long-term Care
02/15/2022
Richard G. Stefanacci, DO, MGH, MBA, AGSF, CMD
Richard G Stefanacci, DO, MGH, MBA, and colleagues discuss how clinical pathways can improve the Quadruple Aim for the management of diabetes in long-term care.
Richard G Stefanacci, DO, MGH, MBA, and colleagues discuss how clinical pathways can improve the Quadruple Aim for the management of diabetes in long-term care.
Richard G Stefanacci, DO, MGH,...
02/15/2022
Journal of Clinical Pathways
Clinical Pathways GPS
Clinical Pathways Improving Management of Rare Conditions
08/19/2021
Richard G. Stefanacci, DO, MGH, MBA, AGSF, CMD
Richard Stefanacci, DO, MGH, MBA, AGSF, CMD, discusses the unique opportunity clinical pathways have to improve the diagnosis of rare diseases, in addition to their role in treatment.
Richard Stefanacci, DO, MGH, MBA, AGSF, CMD, discusses the unique opportunity clinical pathways have to improve the diagnosis of rare diseases, in addition to their role in treatment.
Richard Stefanacci, DO, MGH,...
08/19/2021
Journal of Clinical Pathways
Research Reports
Overactive Bladder Health Care Burden in the US Long-Term Care Setting: A Retrospective Cohort Study
05/18/2021
Drishti Shah, PhD; Jason Yeaw, MPH; Amy Kincaid, MA; Paul N. Mudd, Jr., PharmD, MBA; Richard G. Stefanacci, DO, MGH, MBA, AGSF, CMD
Richard Stefanacci, DO, and colleagues describe and evaluate the population, treatment patterns, HCRU, and costs associated with overactive bladder in the in the US long-term care setting.
Richard Stefanacci, DO, and colleagues describe and evaluate the population, treatment patterns, HCRU, and costs associated with overactive bladder in the in the US long-term care setting.
Richard Stefanacci, DO, and...
05/18/2021
Journal of Clinical Pathways
Engaging Payers
An Alternative Value-Based Care Model for Chronic Conditions
11/18/2020
Lili Brillstein, MPH
Chronic diseases represent a growing burden of morbidity, mortality, and cost worldwide. Individuals requiring chronic care are most vulnerable to the type of care delivered under the fee-for-service (FFS) model,...
Chronic diseases represent a growing burden of morbidity, mortality, and cost worldwide. Individuals requiring chronic care are most vulnerable to the type of care delivered under the fee-for-service (FFS) model,...
...
11/18/2020
Journal of Clinical Pathways
Research Reports
Trend in TKI Use, Adherence, and Switching Patterns in Patients With CML: Before and After the Availability of Generic Imatinib
08/19/2020
Gary H. Lyman, MD, MPH, FASCO, FRCP, FACP; David R. Doody, MS; Shasank Chennupati, PharmD, MPH; Eric J. Chow, MD, MPH; Lena E. Winestone, MD, MSHP; Henry J. Henk, PhD; Pamela Morin, MBA; Jennifer J. Wilkes, MD, MSCE
Abstract: The therapeutic landscape for chronic myeloid leukemia (CML) has evolved substantially over the past decade, most notably with the introduction of second- and third-generation tyrosine kinase inhibitors...
Abstract: The therapeutic landscape for chronic myeloid leukemia (CML) has evolved substantially over the past decade, most notably with the introduction of second- and third-generation tyrosine kinase inhibitors...
...
08/19/2020
Journal of Clinical Pathways
Journal of Clinical Pathways logo

Current Issue

June 2026
Volume 12
Issue 3
Current Issue
Issue Archive

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use